Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Diseases × Leuprolide × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 47 Breast Neoplasms 8 Salivary Gland Neoplasms 2 Prostate Adenocarcinoma 2 Breast Neoplasms, Male 2 Stage I Prostate Adenocarcinoma AJCC v7 1 Salivary Gland Neoplasm Duct 1 Primary Dysautonomias 1 Patient Compliance 1 PSA Level Greater Than Two 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia 1 Kidney Diseases 1 Hypertension 1 Hormone Sensitive Prostate Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 HER2-positive Breast Cancer 1 Granulosa cell tumor of the ovary 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma 1

Interventions

darolutamide 2 olaparib 1 gedatolisib 1 gallium 68 PSMA-11 1 Radiotherapy 1 Prostate-Specific Antigen 1 Pluvicto 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 Cryotherapy 1 Brachytherapy 1 Androgen Antagonists 1 Abiraterone Acetate 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 (225)Ac-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡